Positive Data from BLU-808 Healthy Volunteer Trial Blueprint today announced results from the Phase 1 single-ascending dose (SAD; n=56) and multiple-ascending dose (MAD; n=31, 14-day dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback